BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2021
View Archived Issues
Growth factors linked to lysosomes, Parkinson's risk
Read More
Adding independent costimulation revs up CARs
Read More
Shanghai Longyao receives clinical trial approval in China for LY-007
Read More
FDA clears IND for phase I/II study of VX-880 stem cell-derived therapy for type 1 diabetes
Read More
Life Science Institute initiates exploratory clinical trial of CL-2020 as treatment of ALS
Read More
Janssen's single-shot COVID-19 vaccine shows 85% efficacy in preventing severe disease
Read More
Bukwang concludes enrollment of clinical trial of clevudine as treatment of COVID-19
Read More
Innovation to initiate phase II study of Brilacidin for the treatment of COVID-19
Read More
Nanjing Zhengxiang Pharmaceuticals divulges new MAP4K1 inhibitors
Read More
New MAP4K1 inhibitors discovered at Guangdong Newopp Biopharmaceuticals
Read More
Medshine Discovery patents multitargeted inhibitors of IRAK-4 and BTK
Read More
IGV-001 shows safety and efficacy in phase Ib study in newly diagnosed glioblastoma
Read More
PERK inhibition promising for pulmonary arterial hypertension
Read More
INCB-001158 plus chemotherapy shows promise for treating advanced biliary tract cancer
Read More
Interim data from phase II study of N-803 plus checkpoint inhibitors in NSCLC
Read More
DoD funding supports Rigel's phase III trial of fostamatinib in hospitalized COVID-19 patients
Read More
Small molecule BC-1618 prolongs Ampk biological activity by targeting Fbxo48
Read More
E.U. grants conditional marketing authorization to AstraZeneca COVID-19 vaccine
Read More
Amivantamab produces durable responses in patients with exon 20-mutant NSCLC
Read More
New galectin-1/galectin-3 inhibitors identified at Galecto Biotech
Read More
Allinky Biopharma presents GTPase KRas inhibitors
Read More
TGA clears phase III trial of HLX-04-O for wet AMD
Read More
Topline results from ENHANCE-IT study of Lypdiso in hypertriglyceridemia
Read More
Clover and Dynavax plan H1 initiation of phase II/III trial of adjuvanted COVID-19 vaccine candidate
Read More
FDA lifts clinical hold on ACTION-Galactosemia Kids pediatric study of AT-007
Read More
